Of course. There's no revenue.Is anyone aware of the pricing structure for use of the Ivan-x platform?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025